Mirati Therapeutics, Inc. (MRTX) earnings
Quarterly and annual MRTX reports and results, each read against the price at its own news timestamp. Back to the MRTX overview →
2 measured MRTX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Mirati Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.02% | +0.14% | |
| Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates | Press release | -0.02% | +0.14% |
Keep exploring
More MRTX: analyst actions → · SEC filings → · MRTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aptose Biosciences Inc (APS_TSE) | 110 | 0.00% | 23% |
| DYNATRONICS CORP (DYNT) | 110 | 0.00% | 30% |
| Avinger, Inc. (AVGR) | 108 | -0.24% | 29% |
| Mesoblast Limited - American Depositary Shares (MESO) | 108 | -0.47% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.